Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
15,023,962
Value
$4.52B
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ALNY by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,023,962$4.52B0.2%+444,796+3.1%AddedHolders
Q1 202614,579,166$4.82B0.3%−1,322,983−8.3%ReducedHolders
Q4 202515,902,149$6.32B0.3%−865,476−5.2%ReducedHolders
Q3 202516,767,625$7.65B0.4%+961,104+6.1%AddedHolders
Q2 202515,806,521$5.15B0.3%+496,661+3.2%AddedHolders
Q1 202515,309,860$4.13B0.3%+1,823,957+13.5%AddedHolders
Q4 202413,485,903$3.17B0.2%−1,186,369−8.1%ReducedHolders
Q3 202414,672,272$4.04B0.2%+2,508,234+20.6%AddedHolders
Q2 202412,164,038$2.96B0.2%+2,196,042+22.0%AddedHolders
Q1 20249,967,996$1.49B0.1%−344,360−3.3%ReducedHolders
Q4 202310,312,356$1.97B0.2%−969,050−8.6%ReducedHolders
Q3 202311,281,406$2.00B0.2%−1,211,094−9.7%ReducedHolders
Q2 202312,492,500$2.37B0.2%−678,335−5.2%ReducedHolders
Q1 202313,170,835$2.64B0.2%−341,248−2.5%ReducedHolders
Q4 202213,512,083$3.21B0.3%+562,325+4.3%AddedHolders
Q3 202212,949,758$2.59B0.3%−1,374,991−9.6%ReducedHolders
Q2 202214,324,749$2.09B0.2%−1,720,567−10.7%ReducedHolders
Q1 202216,045,316$2.62B0.2%−1,894,704−10.6%ReducedHolders
Q4 202117,940,020$3.04B0.2%+113,092+0.6%AddedHolders
Q3 202117,826,928$3.37B0.3%+195,199+1.1%AddedHolders
Q2 202117,631,729$2.99B0.2%+81,828+0.5%AddedHolders
Q1 202117,549,901$2.48B0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.